About National Hospital Organization Hirosaki National Hospital
Clinical Trials at National Hospital Organization Hirosaki National Hospital
During the past decade, National Hospital Organization Hirosaki National Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on
average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Hospital Organization Hirosaki National Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Eli Lilly and Company" with 4 trials
sponsored, "Pfizer" with 4 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Shire"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Hirosaki National Hospital"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at National Hospital Organization Hirosaki National Hospital
According to Clinical.Site data, the most researched conditions in "National Hospital Organization Hirosaki National Hospital" are
"Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Respiratory Syncytial Virus Infections" (2 trials), "Colitis, Ulcerative" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Hirosaki National Hospital" in a lesser frequency.
Clinical Trials Intervention Types at National Hospital Organization Hirosaki National Hospital
Most popular intervention types in "National Hospital Organization Hirosaki National Hospital" are "Drug" (17 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Guselkumab" (4 trials), "Mirikizumab" (3 trials), "Golimumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.
Clinical Trials Genders at National Hospital Organization Hirosaki National Hospital
The vast majority of trials in "National Hospital Organization Hirosaki National Hospital" are
17 trials for "All" genders.
Clinical Trials Status at National Hospital Organization Hirosaki National Hospital
Currently, there are NaN active trials in "National Hospital Organization Hirosaki National Hospital".
undefined are not yet recruiting,
5 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in National Hospital Organization Hirosaki National Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Hirosaki National Hospital, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".